Immunicum erhåller Advanced Therapy Medicinal Product-klassificering från EMA för vaccinkandidaten mot canceråterfall, DCP-001
June 28, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande 28 Juni 2021 Immunicum erhåller Advanced Therapy Medicinal Product-klassificering från EMA för vaccinkandidaten mot canceråterfall, DCP-001 Immunicum AB tillkännagav idag att...
Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001
June 28, 2021 02:00 ET
|
Immunicum AB
Press Release 28 June 2021 Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001 Immunicum AB (publ) today announced that...
Immunicum tillkännager inkludering av den första patienten i fas I ALISON-studien som utvärderar vaccinkandidaten DCP-001 vid äggstockscancer
June 23, 2021 02:00 ET
|
Immunicum AB
Pressrelease 23 juni, 2021 Immunicum tillkännager inkludering av den första patienten i fas I ALISON-studien som utvärderar vaccinkandidaten DCP-001 vid äggstockscancer - Första studien för...
Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer
June 23, 2021 02:00 ET
|
Immunicum AB
Press Release 23 June 2021 Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer - First study...